Literature DB >> 22982942

Rho GTPases in pulmonary vascular dysfunction.

Elisabeth M Storck1, Beata Wojciak-Stothard.   

Abstract

Rho proteins, best known for their regulatory role in actin dynamics, stimulate a variety of processes important in the control of vascular function, including morphogenesis, migration, cell proliferation and adhesion, cell survival, gene expression, vesicle transport and microparticle formation. Rho GTPases have been implicated in several pulmonary vascular pathologies. Here we give an overview of the current knowledge of the role of Rho GTPases in vascular dysfunction, and pulmonary diseases such as pulmonary hypertension, pulmonary embolism, chronic obstructive pulmonary disease, acute lung injury and acute respiratory distress syndrome.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22982942     DOI: 10.1016/j.vph.2012.09.004

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  6 in total

1.  Acute Proteomic Changes in the Lung After WTLI in a Mouse Model: Identification of Potential Initiating Events for Delayed Effects of Acute Radiation Exposure.

Authors:  Weiliang Huang; Jianshi Yu; Jace W Jones; Claire L Carter; I Lauren Jackson; Zeljko Vujaskovic; Thomas J MacVittie; Maureen A Kane
Journal:  Health Phys       Date:  2019-04       Impact factor: 1.316

2.  Protein-protein interaction network analysis in chronic obstructive pulmonary disease.

Authors:  Hong Bao; Jiaman Wang; Ding Zhou; Zhaoyong Han; Ling Su; Yuan Zhang; Xiong Ye; Chunyan Xu; Yuping Wang; Qinghua Li
Journal:  Lung       Date:  2013-11-17       Impact factor: 2.584

3.  Tipifarnib prevents development of hypoxia-induced pulmonary hypertension.

Authors:  Lucie Duluc; Blerina Ahmetaj-Shala; Jane Mitchell; Vahitha B Abdul-Salam; Abdul S Mahomed; Lulwah Aldabbous; Eduardo Oliver; Lucio Iannone; Olivier D Dubois; Elisabeth M Storck; Edward W Tate; Lan Zhao; Martin R Wilkins; Beata Wojciak-Stothard
Journal:  Cardiovasc Res       Date:  2017-03-01       Impact factor: 10.787

Review 4.  RhoGTPase in Vascular Disease.

Authors:  Derek Strassheim; Evgenia Gerasimovskaya; David Irwin; Edward C Dempsey; Kurt Stenmark; Vijaya Karoor
Journal:  Cells       Date:  2019-06-06       Impact factor: 6.600

5.  Integrative Proteomic and Phosphoproteomic Analyses of Hypoxia-Treated Pulmonary Artery Smooth Muscle Cells.

Authors:  Ang Luo; Rongrong Hao; Xia Zhou; Yangfan Jia; Haiyang Tang
Journal:  Proteomes       Date:  2022-06-28

6.  Activation of RhoA/Rho-kinase pathway accounts for pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease.

Authors:  Yihua Bei; Sy Duong-Quy; Thong Hua-Huy; Pierre Dao; Nhat-Nam Le-Dong; Anh Tuan Dinh-Xuan
Journal:  Physiol Rep       Date:  2013-10-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.